Shenzhen Chipscreen Biosciences Co., Ltd. announced a private placement for gross proceeds of CNY 260,000,000 on August 5, 2022. The registered capital will increase from CNY 600,000,000 to CNY 860,000,000. The transaction has been approved by Board of directors of the company in the 21st Meeting of the Company's 2nd Directorate and the 12th Meeting of the Company's 2nd Supervisory Board.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.87 CNY | -0.71% | -3.29% | -4.92% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.92% | 1.16B | |
+14.87% | 9.26B | |
-13.94% | 4.92B | |
+48.58% | 4.66B | |
+14.10% | 4.27B | |
+19.66% | 2.44B | |
-25.55% | 2.22B | |
+18.39% | 2.15B | |
-39.57% | 1.89B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 688321 Stock
- News Shenzhen Chipscreen Biosciences Co., Ltd.
- Shenzhen Chipscreen Biosciences Co., Ltd. announced that it expects to receive CNY 260 million in funding